Spire Wealth Management Has $5.69 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)

Spire Wealth Management grew its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 15.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 70,752 shares of the company's stock after acquiring an additional 9,639 shares during the period. Spire Wealth Management's holdings in Colgate-Palmolive were worth $5,687,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. FMR LLC raised its stake in Colgate-Palmolive by 27.3% during the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company's stock valued at $398,055,000 after purchasing an additional 1,199,660 shares during the period. AEGON ASSET MANAGEMENT UK Plc acquired a new stake in Colgate-Palmolive during the 4th quarter valued at $62,728,000. Assenagon Asset Management S.A. raised its stake in Colgate-Palmolive by 92.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,436,054 shares of the company's stock valued at $114,468,000 after purchasing an additional 688,733 shares during the period. Envestnet Asset Management Inc. raised its stake in Colgate-Palmolive by 225.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 930,072 shares of the company's stock valued at $66,137,000 after purchasing an additional 644,205 shares during the period. Finally, Bank of Nova Scotia raised its stake in Colgate-Palmolive by 188.5% during the 3rd quarter. Bank of Nova Scotia now owns 883,272 shares of the company's stock valued at $62,809,000 after purchasing an additional 577,114 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.


Insider Activity

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the company's stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares in the company, valued at approximately $24,161,117.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the business's stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 159,048 shares of company stock worth $13,336,846. Company insiders own 0.37% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CL shares. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an "overweight" rating in a research note on Monday, January 29th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a "buy" rating in a research note on Monday, April 29th. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday, April 16th. Raymond James raised shares of Colgate-Palmolive from a "market perform" rating to an "outperform" rating and set a $91.00 price target on the stock in a research note on Monday, January 29th. Finally, The Goldman Sachs Group initiated coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They issued a "buy" rating and a $93.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $91.44.

Read Our Latest Stock Report on CL

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded up $0.30 during trading on Monday, hitting $93.18. 3,181,735 shares of the stock were exchanged, compared to its average volume of 4,673,507. The company's fifty day simple moving average is $88.49 and its 200-day simple moving average is $82.49. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. The company has a market capitalization of $76.45 billion, a price-to-earnings ratio of 29.49, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $93.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the previous year, the company earned $0.73 earnings per share. The business's revenue was up 6.2% compared to the same quarter last year. Sell-side analysts expect that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.15%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive's payout ratio is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: